Armistice Capital’s Armata Pharmaceuticals ARMP Stock Holding History

Armistice Capital’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-670	Closed	-$371K	–	35
2015 Q3	$371K	Buy	+670	New	+$612K	0.13%	38

Other funds holding ARMP

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital's ARMP Position: Q4 2015 in Review

Armistice Capital sold out of Armata Pharmaceuticals (ARMP) in Q4 2015, closing a stake of 670 shares — an estimated $371K sold.

Armistice Capital first reported a position in ARMP in Q3 2015 and held it in 1 quarter. The position peaked at $371K in Q3 2015. 15 funds tracked by Wall St. Rank hold ARMP as of Q4 2015.

Armistice Capital reported no remaining Armata Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Armistice Capital sold 670 Armata Pharmaceuticals shares in Q4 2015, an estimated $371K.
Armistice Capital first reported a position in Armata Pharmaceuticals in Q3 2015 and held it in 1 quarter.
Armistice Capital's Armata Pharmaceuticals position peaked at $371K in Q3 2015.
15 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2015.

Based on Armistice Capital's 13F filing for Q4 2015, filed 16 Feb 2016.